Breaking News

SSCI Adds ROD SuperNova Diffraction System

Enhances early development support for targeting a crystalline form

By: Kristin Brooks

Managing Editor, Contract Pharma

SSCI, a Division of Albany Molecular Research Inc. (AMRI), located in West Lafayette, IN, has expanded capabilities in the areas of crystalline form indexing and single crystal structure determination, with the addition of the Rigaku Oxford Diffraction (ROD) SuperNova Diffraction System. The system will be operational by April 2016
 
The ROD SuperNova Diffraction System is for small molecule 3D structure analysis and provides SSCI with structure solution capability utilizing a high-performance combination of micro-focus x-ray source and HPAD detector. This instrument will provide SSCI’s scientists with another tool to confirm crystalline form, composition and absolute configuration of the chemical structure. This capability will also allow high-quality x-ray powder diffraction data to be obtained on small amounts of powder samples providing information about particle statistics and preferred orientation effects. 
 
Pamela Smith, Ph.D., senior director and site head at SSCI, said, “The expanded capability enhances our early development support for rapidly targeting a crystalline form and provides our scientists with the ability to obtain valuable crystallographic information for the clients we serve.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters